Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Nvo    crawled time : 23:00    save search

Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Players - Attralus, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Novo Nordisk
Published: 2024-01-24 (Crawled : 23:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.0% C: -0.05%
IONS | $40.81 -0.24% -0.25% 990K twitter stocktwits trandingview |
Health Technology
| | O: 0.38% H: 2.34% C: 1.56%

key growth market
Global Nicotinamide Adenine Dinucleotide Market to Reach $1,722.11 Million by 2032: Increasing Product Penetration Drives Growth
Published: 2023-07-14 (Crawled : 23:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
FNCTF | News | $11.0354 -20.84% 34K twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

reach global growth market
Worldwide Recombinant Protein Industry to 2027: Elevating Prevalence of Several Chronic Diseases Along With the Increasing Demand for Novel Treatment Options Drives Growth
Published: 2023-02-23 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -2.11% H: 0.0% C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.0% H: 0.22% C: 0.1%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.0% C: 0.0%
TECH | $62.25 -0.77% -0.77% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.43% H: 0.25% C: -1.0%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.1% C: -1.34%
ABCM | $23.99 0.0% 7.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.98% C: 0.0%

treatment growth
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 twitter stocktwits trandingview |
Health Technology
| | O: -0.93% H: 3.08% C: 3.08%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.89% H: 1.18% C: 0.52%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 0.2% C: -0.29%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 0.54% C: -0.12%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -3.07% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 1.65% C: 0.94%

treatment patent global report growing diabetes growth market
Novo Nordisk receives FDA approval of higher-dose Ozempic® 2 mg providing increased glycemic control for adults with type 2 diabetes
Published: 2022-03-28 (Crawled : 23:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 2.86% H: 0.47% C: -0.72%

ozempic fda control approval diabetes
Novo Nordisk A/S – Share repurchase programme
Published: 2022-01-31 (Crawled : 23:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.52% H: 1.87% C: 1.67%

program
Novo Nordisk A/S – Share repurchase programme
Published: 2022-01-17 (Crawled : 23:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist


Global Protein Therapeutics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2021-10-18 (Crawled : 23:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 1.66% C: 1.26%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 2.64% C: 1.85%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 1.46% C: 1.36%
BAX | $39.65 0.33% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 1.64% C: 1.58%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.29% C: -0.28%
ABT | News | $105.27 -0.6% -0.15% 7.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 2.67% C: 1.95%
BIIB | $190.55 -0.84% -0.84% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 0.61% C: -0.69%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.67% H: 1.18% C: 1.12%

growth
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.